IP Library › Granted Patent US 8,747,844
Granted Patent B2
US 8,747,844 · App. 13/189,954 · Granted Jun 10, 2014

Methods of treating pain

Inventor: Daniela Salvemini (Chesterfield, MO)
Assignee: Saint Louis University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,747,844
App. No.
13/189,954
Granted
Jun 10, 2014
Kind
B2
Abstract

The invention relates to methods for treating pain disorders including neuropathic and inflammatory pain and to methods to reduce or eliminate nociceptive tolerance induced by opiate analgesic use by administering an agent that suppresses or blocks S1P biological activity.

Claims (7)

1. A method of treating chemotherapy induced neuropathic pain in an individual, the method comprising administering to the individual an effective amount of a drug selected from S1P receptor agonists and S1P receptor antagonists.

2. The method of claim 1 , wherein the chemotherapy comprises the administration of a drug selected from the group consisting of taxanes, platinum compounds, vinca alkaloids, proteasome inhibitors, and combinations thereof.

3. The method of claim 2 , wherein the chemotherapy is selected from the group consisting of paclitaxel, oxaliplatin, bortezomib, vincristine, and combinations thereof.

4. The method of claim 1 , wherein the S1P receptor agonist is selected from the group consisting of Fingolimod, BAF312, Ponesimod, ONO-4641, CS-0777, KRP-203, PF-991, W146, and combinations thereof.

5. A method of treating opiate-induced pain-hypersensitivity in an individual, the method comprising administering to the individual an effective amount of a drug selected from S1P receptor agonists and S1P receptor antagonists.

6. The method of claim 5 , wherein the opiate-induced pain-hypersensitivity is induced by morphine.

7. The method of claim 5 , wherein the S1P receptor agonist is selected from the group consisting of Fingolimod, BAF312, Ponesimod, ONO-4641, CS-0777, KRP-203, PF-991, and W146.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 26, 2012
From: ST. LOUIS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029199/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2011
From: SALVEMINI, DANIELA
To: SAINT LOUIS UNIVERSITY
Reel/Frame 027077/0173 →
Continuity (2)
Provisional Application 61369504 · Jul 30, 2010
Related Publication 20120039866A1 · Feb 16, 2012